What lessons did Sam Whitaker take from building one clinical research tech company to building another?
Whitaker is the cofounder and co-CEO of Mural Health, a Berwyn-based technology company dedicated to making it easy to be a participant in clinical trials. Mural Health’s technology platform, Mural Link, is a patient-first technology that is primarily designed to benefit the study participant, but also improves site operations and drives strategic value to study sponsors. The participant payment solution modernizes the way research sites execute payments and participants receive them.
Prior to Mural Health, Whitaker founded Greenphire, a provider of clinical payment and communication tools. Over 13 years, the company grew and eventually reached a value of over $1 billion with only $2.2 million raised from investors, according to Whitaker.
READ FULL ARTICLE HERE
